Abstract MurA [UDP-N-acetylglucosamine (UDP-NAG) enolpyruvyl transferase] is a key enzyme involved in bacterial cell wall peptidoglycan synthesis and a target for the antimicrobial agent fosfomycin, a structural analog of the MurA substrate phosphoenol pyruvate. In this study, we identiWed, cloned and sequenced a novel murA gene from an environmental isolate of Vibrio Wscheri that is naturally resistant to fosfomycin. The fosfomycin resistance gene was isolated from a genomic DNA library of V. Wscheri. An antimicrobial agent hypersensitive strain of Escherichia coli harboring murA from V. Wscheri exhibited a high fosfomycin resistance phenotype, with minimum inhibitory concentration of 3,000 g/ml. The cloned murA gene was 1,269 bp long encoding a 422 amino acid polypeptide with an estimated pI of 5.0. The deduced amino acid sequence of the putative protein was identiWed as UDP-NAG enolpyruvyl transferase by homology comparison. The MurA protein with an estimated molecular weight of 44.7 kDa was expressed in E. coli and puriWed by aYnity chromatography. MurA of V. Wscheri will be a useful target to identify potential inhibitors of fosfomycin resistance in pharmacological studies.
Introduction
The cell wall of bacteria is composed of alternating units of N-acetylglucosamine and N-acetylmuramic acid interconnected by penta-peptide cross links. The peptidoglycan cell wall determines the cell shape and provides the essential rigidity to withstand the high internal osmotic pressure. The Wrst committed step in the synthesis of bacterial cell wall takes place in the cytoplasm, which involves the addition of enolpyruvate from phosphoenolpyruvate (PEP) to the 3Ј-hydroxyl group of UDP-N-acetylglucosamine (UDP-NAG) with the release of inorganic phosphate (Bugg and Walsh 1992) . This reaction is catalyzed by the enzyme UDP-NAG enolpyruvyl transferase (MurA) (EC 2.5.1.7). MurA is an essential enzyme in Escherichia coli, as its inactivation is lethal to the organism due to the loss of cell integrity and susceptibility to osmotic lysis (Brown et al. 1995) . This enzyme is a target for the antibiotic fosfomycin which inactivates the enzyme by irreversibly binding to the enzyme forming a covalent adduct with the cysteine 115 residue of E. coli MurA (Kahan et al. 1974; Eschenburg et al. 2005; Kim et al. 1996) . Fosfomycin is a broad spectrum bactericidal antibiotic that is eVective against a range of Gram-positive and Gramnegative bacteria. The antibiotic is used to treat uncomplicated urinary tract infections caused by E. coli and Enterococcus faecalis worldwide (Falagas et al. 2008) . Some pathogenic bacteria such as Mycobacterium tuberculosis and Chlamydia trachomatis have been reported to be intrinsically resistant to fosfomycin, and this ability has been attributed to the cysteine-to-aspartate replacement in the active site of the MurA enzyme (De Smet et al. 1999; McCoy et al. 2003) .
Bacteria develop resistance to antimicrobial agents through various mechanisms such as the enzymatic modiWcation or degradation of antibiotics, modiWcations of antibiotic targets or active eZux of antibiotics (Walsh 2000) . The resistance to antimicrobial drugs may be intrinsic or develop due to prolonged exposure to sub lethal concentrations of drugs over a period of time. In the majority of bacteria, fosfomycin is transported into cells via the L--glycerophosphate system (Kahan et al. 1974) . Fosfomycin resistant mutants can appear spontaneously during the course of antibiotic treatment primarily due to mutations in chromosomal glpT, causing failure to transport fosfomycin (Tsuroka and Yamada 1975) . The plasmid encoded glutathione S-transferase enzymes FosA and FosB are implicated in fosfomycin resistance in many species of bacteria (Arca et al. 1990; O'Hara 1993) . The fosA gene is reported to be widely distributed among members of the Enterobacteriaceae and Pseudomonas spp. (Teran et al. 1988) . The presence of fosB in Gram-positive bacteria such as Staphylococcus aureus, Bacillus subtilis and the fosX gene from Mesorhizobium loti and Listeria monocytogenes have been studied in detail with respect to their role in fosfomycin resistance (Cao et al. 2001; Etienne et al. 1991; Fillgrove et al. 2003) .
The objective of our study was to identify and characterize the gene responsible for natural resistance of a Vibrio Wscheri strain to fosfomycin. In this report, we describe the identiWcation, cloning and sequencing of a novel murA gene from V. Wscheri that confers elevated resistance to the cell wall inhibiting antibiotic fosfomycin.
Materials and methods

Bacterial strains and plasmids
The bacterial strains and the plasmids used in this study are listed in the Table 1. V. Wscheri VF107 was grown in a medium consisting of 1% peptone, 0.5% yeast extract and 2% sodium chloride at 30°C. Host E. coli strains KAM32 and SG13009 were grown in Luria Bertani (LB) broth at 37°C. LB broth was supplemented with ampicillin (100 g/ml), kanamycin (25 g/ml) and 1 mM isopropyl--D-thiogalactopyranoside (IPTG) when required. Plasmid extractions were performed using a commercial kit (Qiagen, USA). Electrotransformation was followed for introducing plasmids into E. coli host strains.
Cloning and sequencing of V. Wscheri murA Genomic DNA of V. Wscheri VF107 was extracted following the method of Ausubel et al. (1995) . About 10 g of the pure genomic DNA was digested with the restriction endonuclease enzyme PstI, and the fragments ranging in size from 2-10 kb were puriWed from an agarose gel after electrophoresis. The plasmid vector pSP72 (Promega, USA) was similarly digested, treated with calf intestinal alkaline phosphatase (Fermentas, USA), ligated with the genomic DNA fragments using a LigaFast DNA ligation kit (Promega, USA) and transformed into E. coli KAM32 (Chen et al. 2002) The transformants were screened on LB agar plates containing 100 g/ml each of ampicillin and fosfomycin. A 1.7-kb insert was sequenced by dideoxy chain termination procedure on both strands using vector speciWc primers.
Determination of minimum inhibitory concentration
The minimum inhibitory concentrations (MICs) of fosfomycin to V. Wscheri VF107 and E. coli KAM32/pSP72/VfmurA were determined in Mueller Hinton broth following the CLSI microbroth dilution procedure (CLSI 2006) . The assay was performed in a 96-well microtiter plate with appropriate uninoculated media blanks. The test strains were grown to an OD 625 of 0.4, washed and resuspended in fresh MH broth to yield 10 3 -10 4 cells/ml. A serial tenfold dilution of the stock antibiotic was performed in MH broth in microtitre plate wells and inoculated with the test strains. The plates were incubated at 37°C for 24 h, and the growth was examined visually. The assay was repeated thrice, and the lowest concentration of fosfomycin that inhibited growth was recorded as the MIC for the test strains.
Overexpression and puriWcation of murA in E. coli Primers FM-F (5Ј-ATGGATAGCGCCGAGATTAA-3Ј) and FM-R (5Ј-TAAGTCGTCGCTATGAACT-3Ј) were The 6 £ His-tagged MurA fusion protein was puriWed by using nickel chromatography columns following the manufacturer's protocol (Qiagen, USA). BrieXy, the recombinant E. coli SG/pQE30/Vf-murA was grown in LB broth containing 100 g/ml ampicillin and 25 g/ml kanamycin to an OD 600 of 0.5, induced with 1 mM IPTG and further incubated for 8 h with shaking. The cells were harvested by centrifugation at 3,000£g for 15 min., and the pellet was lysed using a lysis buVer (6 M GuHCl, 0.1 M NaH 2 PO 4 , 0.01 M Tris-Cl, pH 8.0) and centrifuged at 11,000 g for 15 min. at room temperature to pellet the cellular debris. The supernatant was loaded onto Ni-NTA aYnity columns, centrifuged and the column was washed twice with wash buVer (6 M GuHCl, 0.1 M NaH 2 PO 4 , 0.01 M Tris-Cl, pH 6.3). The bound recombinant protein was eluted with elution buVer (6 M GuHCl, 0.1 M NaH 2 PO 4 , 0.01 M Tris-Cl, pH 4.5), dialyzed against Tris buVer (10 mM Tris-Cl pH 8.0, 0.1% Triton X-100) overnight at 4°C to remove guanidine hydrochloride. The recombinant protein was electrophoresed on a 12% sodium dodecyl sulfate polyacrylamide gel and visualized by staining with Coomassie brilliant blue.
Sequence analysis
The nucleotide sequence derived was subjected to a GenBank homology search using a standard nucleotide-nucleotide BLAST analysis (Altschul et al. 1997 ). The deduced amino acid sequence of V. Wscheri MurA was analyzed for conserved domains at http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi (Marchler-Bauer et al. 2007 ) and was compared with other homologous sequences in GenBank using the CLUSTAL W multiple sequence alignment program (Higgins et al. 1994 ).
Nucleotide sequence
The nucleotide sequence derived in this study has been deposited in the GenBank with the accession number FJ172353.
Results and discussion
Vibrio Wscheri is a marine bacterium that is either free living or lives in symbiotic association with some marine squids and Wsh (Ruby and McFall-Ngai 1999) . Marine environments have diverse species of bacteria and fungi producing varieties of bioactive compounds, including antibiotics (Bernan et al. 1997) . Bacteria living in such a competitive environment tend to develop natural resistance to antibiotics as a strategy to overcome the lethal eVects of inhibitory compounds produced by competing bacteria in the same niche. Thus, it is likely that antibiotic resistant bacteria are encountered in the marine environment, despite the fact that bacteria are not considered clinically important and the antibiotic resistance phenotype has not evolved due to exposure to chemotherapeutic use of antibiotics. We found that V. Wscheri VF107 was naturally resistant to the antibiotic fosfomycin that could not be attributed to any plasmid-borne gene. In order to identify the gene responsible for fosfomycin resistance, we created a genomic DNA library of V. Wscheri in an antimicrobial agent hypersensitive strain E. coli KAM32 (Chen et al. 2002) and screened for fosfomycin resistant clones. This yielded E. coli KAM32/psp72/Vf-murA harboring a V. Wscheri genomic fragment of 2,400 bp. Sequence analysis of the gene revealed two putative open reading frames consisting of a 258-bp toluene tolerance gene ttg2F, followed by a gene encoding UDP-NAG 1-carboxy vinyl transferase (murA). At the 3Ј-end, a partial sequence of the gene encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase was identiWed. The organization of the murA gene in V. Wscheri was found to be identical with that of V. salmonicida, the whole genome sequences of which are currently available. In the genomes of these two species, the murA gene is preceded by predicted toluene tolerance genes ttg2A, ttg2B, ttg2C, ttg2D and ttg2F.
The MICs of fosfomycin were determined for the host E. coli strain KAM32, V. Wscheri from which the murA gene was cloned and E. coli KAM32/pSP72/Vf-murA. The results are presented in Table 2 . E. coli KAM32 was highly sensitive to fosfomycin with an MIC of 32.5 g/ml. E. coli KAM32/pSP72/Vf-murA had an MIC of 3,000 g/ml, which was about half of the MIC obtained with V. Wscheri VF107 (MIC = 6,000 g/ml). The reason for this diVerence in MIC levels could not be determined in this study. Sequence analysis of the cloned murA gene from V. Wscheri revealed that the gene is 1,269 bp encoding a polypeptide of 422 amino acids with a calculated pI of 5.0. The murA gene was ampliWed, cloned and over expressed in E. coli SG13009. The 6 £ Histidine tagged MurA protein was puriWed by metal aYnity chromatography under denaturation conditions. The pure recombinant MurA exhibited a molecular mass of about 45 kDa (Fig. 1) . This value corresponded well with the calculated mass of 44.7 kDa (Fig. 1) . At this stage, our attempts to purify native recombinant MurA protein using imidazole in the elution buVer were not successful, possibly due to the aYnity tag being hidden in the protein folds.
In E. coli fosfomycin inactivates MurA irreversibly by forming a covalent adduct with nucleophilic cysteine 115 present in the catalytic site of the enzyme (Kahan et al. 1974; Marquardt et al. 1992) . Later studies have revealed that replacement of Cys-115 with aspartate renders E. coli MurA resistant to fosfomycin. Organisms with a Cys ! Asp replacement at position 115 in their MurA proteins are naturally resistant to fosfomycin, such as in the case of Mycobacterium tuberculosis and Chlamydia trachomatis (De Smet et al. 1999; McCoy et al. 2003) . We compared the deduced amino acid sequence of V. Wscheri MurA with the homologous sequences from V. salmonicida, E. coli and M. tuberculosis. Overall, V. Wscheri MurA was 95% identical with the corresponding sequence of V. salmonicida, 79% identical with the MurA of E. coli K12 and 43% with M. tuberculosis MurA (Fig. 2) . The Cys-115 residue of E. coli MurA corresponds to Cys-116 of E. coli K12 and Cys-117 of M. tuberculosis. This residue is absolutely conserved in V. Wscheri MurA. Based on sequence analysis, we could not determine why V. Wscheri MurA was less susceptible to binding by fosfomycin. A number of highly conserved amino acids could be observed in the enzyme from diverse sources, the functions of which are not known. Speculatively, it is possible that a yet undiscovered sequence variant elsewhere along the peptide is responsible for fosfomycin resistance observed in this study. Further work will be necessary to test this hypothesis.
Our future work will focus on the functional characterization of the MurA protein from V. Wscheri and determining amino acids responsible for fosfomycin resistance by site directed mutagenesis.
